Journal article
Robust Measures of Image-Registration-Derived Lung Biomechanics in SPIROMICS
Journal of imaging, Vol.8(11), p.309
11/16/2022
DOI: 10.3390/jimaging8110309
PMCID: PMC9693030
PMID: 36422058
Abstract
Chronic obstructive pulmonary disease (COPD) is an umbrella term used to define a collection of inflammatory lung diseases that cause airflow obstruction and severe damage to the lung parenchyma. This study investigated the robustness of image-registration-based local biomechanical properties of the lung in individuals with COPD as a function of Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage. Image registration was used to estimate the pointwise correspondences between the inspiration (total lung capacity) and expiration (residual volume) computed tomography (CT) images of the lung for each subject. In total, three biomechanical measures were computed from the correspondence map: the Jacobian determinant; the anisotropic deformation index (ADI); and the slab-rod index (SRI). CT scans from 245 subjects with varying GOLD stages were analyzed from the SubPopulations and InteRmediate Outcome Measures In COPD Study (SPIROMICS). Results show monotonic increasing or decreasing trends in the three biomechanical measures as a function of GOLD stage for the entire lung and on a lobe-by-lobe basis. Furthermore, these trends held across all five image registration algorithms. The consistency of the five image registration algorithms on a per individual basis is shown using Bland–Altman plots.
Details
- Title: Subtitle
- Robust Measures of Image-Registration-Derived Lung Biomechanics in SPIROMICS
- Creators
- Yue Pan - University of IowaDi Wang - University of IowaMuhammad F. A. Chaudhary - University of IowaWei Shao - University of IowaSarah E. Gerard - University of IowaOguz C. Durumeric - University of IowaSurya P. Bhatt - University of IowaR. Graham Barr - University of IowaEric A. Hoffman - University of IowaJoseph M. Reinhardt - University of IowaGary E. Christensen - University of Iowa
- Resource Type
- Journal article
- Publication Details
- Journal of imaging, Vol.8(11), p.309
- DOI
- 10.3390/jimaging8110309
- PMID
- 36422058
- PMCID
- PMC9693030
- NLM abbreviation
- J Imaging
- eISSN
- 2313-433X
- Publisher
- MDPI
- Grant note
- Chiesi Farmaceutici S.p.A. Regeneron Pharmaceuticals, Inc. Theravance Biopharma and Mylan Grifols Therapeutics, Inc. ProterixBio HL142625 / NIH AstraZeneca/MedImmune HHSN268200900013C; HHSN268200900014C; HHSN268200900015C; HHSN268200900016C; HHSN268200900017C; HHSN268200900018C; HHSN268200900019C; HHSN268200900020C; U01 HL137880; U24 HL141762 / NIH/NHLBI Takeda Pharmaceutical Company Novartis Pharmaceuticals Corporation Carver Charitable Trust Bellerophon Therapeutics GlaxoSmithKline Bayer Sunovion Boehringer-Ingelheim Pharmaceuticals, Inc. Sanofi Ikaria, Inc. Nycomed GmbH Forest Research Institute, Inc.
- Language
- English
- Date published
- 11/16/2022
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Radiology; Electrical and Computer Engineering; Radiation Oncology; The Iowa Institute for Biomedical Imaging; Mathematics; Advanced Pulmonary Physiomic Imaging Laboratory; Holden Comprehensive Cancer Center; Internal Medicine
- Record Identifier
- 9984318684402771
Metrics
13 Record Views